Performance of the BinaxNOW coronavirus disease 2019 (COVID-19) Antigen Card test relative to the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) real-time reverse transcriptase polymerase chain reaction (rRT-PCR) assay among symptomatic and asymptomatic healthcare employees.
Performance of the BinaxNOW coronavirus disease 2019 (COVID-19) Antigen Card test relative to the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) real-time reverse transcriptase polymerase chain reaction (rRT-PCR) assay among symptomatic and asymptomatic healthcare employees.
复制标题
DOI：
10.1017/ice.2021.20
复制
发表时间：
2022-01
影响因子：
4.5
通讯作者：
Patil N
中科院分区：
文献类型：
--
作者：
James AE;Gulley T;Kothari A;Holder K;Garner K;Patil N
在无症状的医护人员中，新冠肺炎(BinaxNOW)银卡检测(BinaxNOW)相对于实时逆转录聚合酶链式反应(RRT-PCR)的敏感度为51.6%。BinaxNOW试验阳性的几率随着周期阈值的增加而降低。在某些情况下，BinaxNOW可以在等待RRT-PCR结果的情况下促进对无症状感染者的快速检测和隔离。
The sensitivity of the BinaxNOW coronavirus disease 2019 (COVID-19) Ag Card test (BinaxNOW) was 51.6% among asymptomatic healthcare employees relative to real-time reverse transcriptase polymerase chain reaction (rRT-PCR). The odds of a positive BinaxNOW test decreased as cycle threshold value increased. BinaxNOW could facilitate rapid detection and isolation of asymptomatically infected persons in some settings while rRT-PCR results are pending.